Literature DB >> 852577

Maytansine binding to the vinblastine sites of tubulin.

B Bhattacharyya, J Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 852577     DOI： 10.1016/0014-5793(77)80075-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  20 in total

Review 1.  Antimicrotubular drugs binding to vinca domain of tubulin.

Authors:  Suvroma Gupta; Bhabatarak Bhattacharyya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  Demonstration of microtubule-like structures formed with (-)-rhazinilam from purified tubulin outside of cells and a simple tubulin-based assay for evaluation of analog activity.

Authors:  Michael C Edler; Guangli Yang; M Katherine Jung; Ruoli Bai; William G Bornmann; Ernest Hamel
Journal:  Arch Biochem Biophys       Date:  2009-06-02       Impact factor: 4.013

Review 3.  Antibody-DM1 conjugates as cancer therapeutics.

Authors:  Manu Lopus
Journal:  Cancer Lett       Date:  2011-04-09       Impact factor: 8.679

Review 4.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

5.  A "Dual" Cell-Level Systems PK-PD Model to Characterize the Bystander Effect of ADC.

Authors:  Aman P Singh; Dhaval K Shah
Journal:  J Pharm Sci       Date:  2019-02-18       Impact factor: 3.534

6.  Maytansinoid-antibody conjugates induce mitotic arrest by suppressing microtubule dynamic instability.

Authors:  Emin Oroudjev; Manu Lopus; Leslie Wilson; Charlene Audette; Carmela Provenzano; Hans Erickson; Yelena Kovtun; Ravi Chari; Mary Ann Jordan
Journal:  Mol Cancer Ther       Date:  2010-10       Impact factor: 6.261

7.  Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules.

Authors:  Manu Lopus; Emin Oroudjev; Leslie Wilson; Sharon Wilhelm; Wayne Widdison; Ravi Chari; Mary Ann Jordan
Journal:  Mol Cancer Ther       Date:  2010-10       Impact factor: 6.261

8.  A screen for kinetochore-microtubule interaction inhibitors identifies novel antitubulin compounds.

Authors:  Emanuela Screpanti; Stefano Santaguida; Tam Nguyen; Romano Silvestri; Rick Gussio; Andrea Musacchio; Ernest Hamel; Peter De Wulf
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

9.  Evolution of Antibody-Drug Conjugate Tumor Disposition Model to Predict Preclinical Tumor Pharmacokinetics of Trastuzumab-Emtansine (T-DM1).

Authors:  Aman P Singh; Katie F Maass; Alison M Betts; K Dane Wittrup; Chethana Kulkarni; Lindsay E King; Antari Khot; Dhaval K Shah
Journal:  AAPS J       Date:  2016-03-30       Impact factor: 4.009

10.  Removal of the projection domain of microtubule-associated protein 2 alters its interaction with tubulin.

Authors:  A Fellous; V Prasad; R Ohayon; M A Jordan; R F Ludueña
Journal:  J Protein Chem       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.